Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ya‐Li Yu"'
Autor:
Yan‐Da Li, Jiří Kolibáč, Zhen‐Hua Liu, Adam Ślipiński, Shûhei Yamamoto, Ya‐Li Yu, Wei‐Ting Zhang, Chen‐Yang Cai
Publikováno v:
Ecology and Evolution, Vol 14, Iss 7, Pp n/a-n/a (2024)
Abstract Beetles have a remote evolutionary history dating back to the Carboniferous, with Mesozoic fossils playing a pivotal role in elucidating the early evolution of extant families. Despite their exceptional preservation in amber, deciphering the
Externí odkaz:
https://doaj.org/article/032fc2874f114fcf90a59e5a52432610
Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers
Autor:
Qing-Lan Li, Xiang Lin, Ya-Li Yu, Lin Chen, Qi-Xin Hu, Meng Chen, Nan Cao, Chen Zhao, Chen-Yu Wang, Cheng-Wei Huang, Lian-Yun Li, Mei Ye, Min Wu
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Active enhancers are still understudied in colorectal cancers (CRC). Here the authors analyse active enhancers in CRC patients using genomics, transcriptomics, and epigenomics, identifying and validating variant super-enhancer loci as well as KLF3 as
Externí odkaz:
https://doaj.org/article/674cf176220842dd92978ff6bc45defa
Publikováno v:
Insects, Vol 12, Iss 12, p 1052 (2021)
A new genus and species of the cleroid family Lophocateridae are described and illustrated from the mid-Cretaceous amber of northern Myanmar. Gracilenticrus burmiticus Yu, Kolibáč & Ślipiński gen. et sp. nov. is unique among Lophocateridae in the
Externí odkaz:
https://doaj.org/article/cf83f8a528dd45cc87bba613aea33c97
Autor:
Yan-Da Li1, Ya-Li Yu2, Jäch, Manfred A.3, Di-Ying Huang1, Chen-Yang Cai1,4 cycai@nigpas.ac.cn
Publikováno v:
Zoologia. 2022, Vol. 39, p1-8. 8p.
Autor:
Yu-Juan Mao, Hua Zhu, Qiu Zhao, Mei Ye, Mingxing Zhuo, Min Chen, Ya-Li Yu, Lian-Yun Li, Ping Chen, Min Wu
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:2850-2863
BACKGROUND AND AIM Epigenetic modification is an important part of the pathogenesis of inflammatory bowel disease (IBD). Some studies proved that p62 was involved in inflammatory response and upregulated in IBD patients, and histone modification play
Autor:
Meng Chen, Yu-Juan Mao, Qiu Zhao, Ping Chen, Mei Ye, Mingxing Zhuo, Hua Zhu, Lian-Yun Li, Ya-Li Yu, Min Wu
Publikováno v:
Clinical Epigenetics
Background The aetiology of inflammatory bowel disease (IBD) is related to genetics and epigenetics. Epigenetic regulation of the pathogenesis of IBD has not been well defined. Here, we investigated the role of H3K27ac events in the pathogenesis of I
Autor:
Lin Chen, Mei Ye, Meng Chen, Nan Cao, Qi-Xin Hu, Xiang Lin, Lian-Yun Li, Cheng-Wei Huang, Ya-Li Yu, Min Wu, Chen Zhao, Chen-Yu Wang, Qing-Lan Li
Colorectal cancer (CRC) is one of the most common cancers in the world. Although genomic mutations and SNPs have been extensively studied, the epigenomic status in CRC patient tissues remains elusive. Here, we profiled active enhancers genome-widely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3777b632a25d30bd288ea357cd4498f6
https://doi.org/10.21203/rs.3.rs-119156/v1
https://doi.org/10.21203/rs.3.rs-119156/v1
Autor:
Qiu Zhao, Yu-Juan Mao, Meng Chen, Ping Chen, Ya-Li Yu, Lian-Yun Li, Nan Cao, Mingxing Zhuo, Min Wu, Mei Ye, Hua Zhu
Publikováno v:
Cell Death and Disease, Vol 11, Iss 5, Pp 1-13 (2020)
Cell Death & Disease
Cell Death & Disease
SETDB1, a histone H3K9 methyltransferase, has been reported to be upregulated in a variety of tumors and promotes cancer development. However, the exact pathogenesis of SETDB1 in human colorectal cancer (CRC) is hitherto unknown. Here, we showed that
Publikováno v:
Current medical science. 40(5)
Although the exact etiology of inflammatory bowel disease (IBD) remains unclear, exaggerated immune response in genetically predisposed individuals has been reported. Th1 and Th17 cells mediate IBD development. Macrophages produce IL-12 and IL-23 tha
Publikováno v:
World Journal of Gastroenterology
Aim To summarize and compare the clinical characteristics of drug-induced liver injury (DILI) and primary biliary cirrhosis (PBC). Methods A total of 124 patients with DILI and 116 patients with PBC treated at Shengjing Hospital Affiliated to China M